Citywire: The Selection Show

Citywire: The Selection Show

By CitywireBusiness
Download on the App Store

Citywire: The Selection Show episodes

  • ‘Deep in the risk-avoidance dugout’: Jeremy Grantham interview in full
    PODCAST: Citywire Selector spoke at length with the GMO founder and value stalwart about his current market thinking.

    ‘Value tends to prosper’. As far as mantras to live by, Jeremy Grantham is very committed to the idea that buying discounted stocks and making money as they prove the doubters wrong is a way to earn a living.

    In this extended interview, the GMO founder outlines why he believes the latest rotation in market styles is more meaningful than some that have gone before, while also explaining why the hot pocket of recent growth - technology - might now be sitting right in his wheelhouse.

    Also in this discussion, we expand on previous points about alternative investing and fears over ‘super bubbles’ being driven by herd mentality, as well as his thoughts about income inequality and being one of the early proponents of climate-aware investing.
    20 min
  • MedTech Under The Microscope: medtech versus the pharmaceutical industry
    Alliance Bernstein’s Vinay Thapar talks about the incredible innovation of the medtech sector versus a slower advancement within the traditional pharmaceutical industry.

    In the fifth episode of its MedTech podcast, Citywire Selectors meets Vinay Thapar, fund manager at Alliance Bernstein.

    Thapar, who has been investing in the healthcare space for over two decades and oversees the AB International Health Care fund, talks about the long-term advantages of a thematic strategy and the two main factors that define a successful investable business. When selecting stocks, the fund manager looks at the company’s return on invested capital to determine its efficiency, while also considering the firm’s reinvestment rate.
    Thapar’s bottom-up investing strategy guarantees a risk-aware portfolio which benefits from the best available opportunities, which are not necessarily linked to a specific country or sub-sector.

    But what are the main trends and opportunities that lay ahead within the healthcare space? Thapar highlights the current progress in diagnostics triggered by the advances in genome sequencing technology and new tests that will allow to detect cancer faster and more accurately than now. Also on the list are both minimally invasive technology with the rise of surgical robotics, and the implementation of catheter-based technologies.

    This episode was recorded on February 25 (2022).
    9 min
  • MedTech Under The Microscope: Healthcare in the digital era PODCAST: Bellavue’s Stefan Blum talks about his two healthcare strategies and the way digitalisation has been shaping the medtech sector over the last decade.
    While stressing how digitalisation has been embedded within both the medtech and the general health care space over the last few years, Blum highlights his two strategies’ overarching themes, as well as the key differences between the Bellevue Medtech & Services fund and the Bellavue Digital Health fund he oversees.

    American medical devices and health care producer Abbott Laboratories is one of the large caps the first fund invests in, to concurrently secure stability and growth. The Bellavue Digital Health fund, on the other hand, is mainly tilted towards exponential growth digital health companies like Shockwave Medical, which produces cardiovascular medical devices.

    In this episode Blum also talks about forthcoming products which are expected to drive market growth and more specifically, he is eyeing names within robotic assisted surgery, structural heart disease treatment and diabetes care.

    This episode was recorded on February 11 (2022).
    10 min
  • Are parts of the private markets really like Ponzi schemes?
    There were two reasons Amundi’s Vincent Mortier said parts of the private markets resembled Ponzi schemes. The first is the idea of leverage is often miscommunicated and the second is that value is hard to properly ascertain.

    That is the view of Cyril Demaria, independent consultant and private markets expert. In this special podcast, Demaria, who has more than 20 years industry experience and was formerly CIO of private markets at UBS Wealth Management, discusses the reality of the private markets landscape today.

    Also in this discussion, Demaria discusses the challenge of ensuring proper outperformance in a market famed for its limited transparency and also offers his tips for being able to select a private equity fund to fit your portfolio.
    19 min
  • MedTech Under The Microscope Ep3: the importance of sustainability within the sector
    During the third episode of its MedTech podcast, Citywire Selectors meets co-head of BMO GAM’s global equities team Jamie Jenkins.
    He talks about the challenges the MedTech sector has been facing over the last couple of years, and how those hurdles have added to long-term issues like diabetes and an ageing population.

    Jenkins shares details of his three-step approach which consists in avoiding companies with damaging or unsustainable business practices, while investing in names that make a positive contribution to the society, and/or the environment. Within this strategy, Jenkins and his team want to facilitate and promote best practice management of environmental, social and governance issues, through long-term ownership of companies.

    The co-head is also lead portfolio manager of both the BMO Responsible Global Equity fund and the BMO SDG Engagement Global Equity fund, and these strategies’ healthcare holdings contribute towards ‘health and wellbeing’, which is one of the United Nations Sustainable Development Goals. Both medical equipment provider Thermo Fisher Scientific and genetic variation equipment developer Illumina, are on the list.

    During this episode Jenkins also explains the overwhelming exposure to US healthcare holdings within his funds, as well as the reason certain Asian countries have become the epicentre of telemedicine development.

    This episode was recorded on February 11 (2022).
    12 min
  • MedTech Under The Microscope Ep2 - Novel technologies can address large unmet medical needs
    In the second episode of its MedTech podcast, Citywire Selectors meets Paul Loudon, investment manager at Walter Scott & Partners.
    Loudon, who oversees the BNY Mellon Long Term Global Equity fund, talks about his long-term, high conviction strategy and the best way to access medical technology products and companies with a long runway for growth.

    At the core of his approach is the aim to invest in MedTech business solutions that benefit all three key stakeholders: the patient, the health system, and the investor.

    Artificial heart valves & hemodynamic monitoring company Edwards Lifesciences, together with robotic surgery company Intuitive Surgical, sit at the top of the list of healthcare holdings within the fund. While the equipment produced by both companies is equally expensive and sophisticated, it provides safer and effective procedures, which make the investment worthwhile in the medium-long term.

    This episode was recorded on February 4 (2022).
    11 min
  • MedTech Under The Microscope Ep1 Unconstrained investing & the role of genomics in an ageing society
    Kicking off the series is Zehrid Osmani, head of global long-term unconstrained at Martin Currie.
    With a fifth of his portfolio tilted towards healthcare, Osmani achieves structural growth by focusing on areas of attraction, without letting index exposure dictate his choices.
    Demographic changes, resource scarcity and an exponential growth of technology across all economy sectors, are the megatrends at the hearth of his strategy.
    But what new areas are consolidating within the healthcare space?
    Genomics, which is leading the way to tailor made therapies based on everybody's genetic profile, is certainly on the list. And guess what, the cost of sequencing a genome has decreased from $54m in 2003, to just $600 at present!

    This episode was recorded on February 4 (2022).
    18 min
  • Let's Talk About ESG Ep.26: Going beyond the number of ESG experts and their CVs
    If you’re making sustainability hires for marketing purposes, it will quickly become clear it’s not going to work or it won’t have a true impact on the business.

    When selecting funds, Anne Ackerman, former head of impact fund selection at Credit Suisse, always paid attention to interactions between portfolio managers and ESG analysts to make sure that their approach to sustainability was robust enough.

    ‘It is not about the number of people, CVs of those people, but more about the commitment of the business and people running the business; how they actually support sustainability experts.’

    In her view it is not just about integrating sustainability into the investment process but also about the role it plays for companies themselves, be it the wellbeing of employees or how a given firm sets environmental or climate targets.

    'If this is not supported at the high level – at some point there probably will be struggles, but I think it is an important aspect to look at.’

    Also in this podcast former fund buyer explains why she likes ESG approach of boutiques and what is the difference between impact and ESG fund selection.
    33 min
  • Breaking and Entering S2 Ep.6: Why this ex-Pimco PM ditched the industry (twice)
    Jeremie Banet once was a fund manager at Pimco. However, after a few years in finance, he decided that he needed to experience something more tangible.

    After setting up a French food truck company, which didn’t succeed, he tried to mix both worlds, returning to the US firm as lead portfolio manager of global inflation-linked bond funds.

    However, Banet again decided to leave asset management for good to become an academic on digital currencies and is currently a PhD student at the University of California Irvine.

    For the last episode of this second series of Breaking and Entering, we uncover a ‘lost tape’ from our first season, which was helmed by former Citywire Selector reporter Victoire Barbin Perron.
    29 min
  • Breaking & Entering S2 Ep.5: From sharing a tennis court with Anna Kournikova to value investing
    Brokers in Wall Street still tell stories about the time 'Queen of the Court' Regina Borromeo remained undefeated for years during her years in Manhattan.

    After all, to win various tennis and squash championships at university and share courts with some of the most renowned players in the world is something very few people get to do.

    Nevertheless, while she managed to handle both her sports and educational careers during her teenage years, Borromeo decided that going professional wasn't for her. However, she kept her passion high up in her priorities list.

    She competed with the Philippines team in the Asian Games in 2018 against rivals half her age, before becoming director of global macro fixed income at Robeco.
    38 min

About Citywire: The Selection Show

From the publisher's feed

We go on-the-ground to hear first-hand what top selectors and managers are focusing on.